Literature DB >> 16032799

Hepatitis A, Italy.

Raffaele D'Amelio, Alfonso Mele, Andrea Mariano, Luisa Romanò, Roberto Biselli, Florigio Lista, Alessandro Zanetti, Tommaso Stroffolini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16032799      PMCID: PMC3371791          DOI: 10.3201/eid1107.041157

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Hepatitis A virus (HAV) infection rates are very low in industrialized countries. A noticeable fall in the prevalence of HAV antibodies (anti-HAV) has been reported in southern European and Mediterranean countries such as Spain () and Greece (), reflecting improvements in hygiene standards in the last decades. An HAV prevalence of 66.3% in 1981 () and 29.4% in 1990 () was shown in studies conducted in military recruits from all Italian regions. In both studies, subjects from southern regions had a higher HAV prevalence than those from north-central regions. In 2003, we conducted a study of recruits to show changes in HAV infection prevalence in younger Italian generations. Military service was compulsory in Italy at that time; all men 18–26 years of age were included. From September to December 2003, 323 recruits 18–26 years of age (mean age 20 years), representing all Italian regions, who had been accepted for Air Force military service were tested for anti-HAV in the recruitment center at Viterbo. This recruitment center, used in the 1990 study, was chosen again because it is located near Rome and adherence to protocol was easier to control. A standard, precoded questionnaire was designed to collect information in the same sequence as questions asked by military personnel during the examination. The same information was collected as in the previous studies: date of birth, residence, father's years of education, and family size. After informed consent was obtained, blood samples were collected and stored at –30°C until tested. No person was vaccinated against HAV. Anti-HAV assay was performed by using commercial immunoenzymatic method (Abbot Laboratories, North Chicago, IL, USA). The methods used in the 1981 and 1990 studies have similar sensitivity and specificity between them and in relation to that used in the current study, and are detailed elsewhere (,). The prevalence of anti-HAV declined from 66.3% in 1981 to 5.3% in 2003 (p<0.01, χ2 test). In 2003, the prevalence was 2.1% in the north-central region and 7.9% in southern regions (Figure). However, southern residents were more likely to have been exposed to HAV than north-central residents (p<0.02, χ2 test). No statistical difference relative to father's years of education or family size was shown. Basic requirements for Navy (1981 study) and Air Force (1990 and 2003 studies) enrollment were similar. Thus, the 3 studies are comparable and a valid estimation of epidemiologic changes over time.
Figure

Anti-hepatitis A virus prevalence, 1981–2003.

Anti-hepatitis A virus prevalence, 1981–2003. The anti-HAV prevalence shown in this study (5.3%) indicates that Italy has very low endemicity of HAV infection, at least in the young male population. The decline of HAV infection for >20 years is a consequence of good sanitation and hygienic conditions (vaccination against HAV is rarely performed in Italy) and has generated an increasing proportion of adults who are susceptible to this virus at an age characterized by the likely occurrence of a more severe clinical illness (). This situation will likely necessitate costly interventions, such as vaccinating risk groups (e.g., military personnel, healthcare workers), to prevent HAV infection. Thus, HAV vaccination has been included in the compulsory vaccination schedule of the Italian military personnel since 1998 ().
  6 in total

1.  Vaccination programmes in the Italian military.

Authors:  Raffaele D'Amelio; Roberto Biselli; Sergio Natalicchio; Florigio Lista; Mario S Peragallo
Journal:  Vaccine       Date:  2003-09-08       Impact factor: 3.641

2.  A large percentage of the Spanish population under 30 years of age is not protected against hepatitis A.

Authors:  R Dal-Ré; P García-Corbeira; J García-de-Lomas
Journal:  J Med Virol       Date:  2000-04       Impact factor: 2.327

3.  The changing epidemiology of hepatitis A in Italy.

Authors:  T Stroffolini; R D'Amelio; P M Matricardi; P Chionne; A Napoli; M Rapicetta; S Crateri; P Pasquini
Journal:  Ital J Gastroenterol       Date:  1993 Aug-Sep

4.  Epidemiology of hepatitis A in Mediterranean countries.

Authors:  G Papaevangelou
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

Review 5.  [Hepatitis A virus infection. A review].

Authors:  G Siegl
Journal:  Praxis (Bern 1994)       Date:  2003-10-01

6.  Prevalence of hepatitis A antibodies in Italy.

Authors:  P Pasquini; H A Kahn; D Pileggi; A Panà; J Terzi; T D'Arca
Journal:  Int J Epidemiol       Date:  1984-03       Impact factor: 7.196

  6 in total
  7 in total

1.  Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study.

Authors:  Filippo Ansaldi; Bianca Bruzzone; Maria Cristina Rota; Antonino Bella; Marta Ciofi degli Atti; Paolo Durando; Roberto Gasparini; Giancarlo Icardi
Journal:  Eur J Epidemiol       Date:  2007-11-03       Impact factor: 8.082

2.  Seroepidemiology of HEV and HAV in two populations with different socio-economic levels and hygienic/sanitary conditions.

Authors:  M Zuin; C Caserta; L Romanò; A Mele; A Zanetti; R Cannatelli; A Giorgini; C Tagliacarne; A Amante; F Marcucci; P M Battezzati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-26       Impact factor: 3.267

3.  Marked decrease in the incidence and prevalence of hepatitis A in the Basque Country, Spain, 1986-2004.

Authors:  G Cilla; E Pérez-Trallero; J Artieda; E Serrano-Bengoechea; M Montes; D Vicente
Journal:  Epidemiol Infect       Date:  2006-07-19       Impact factor: 2.451

Review 4.  A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.

Authors:  Roberto Biselli; Roberto Nisini; Florigio Lista; Alberto Autore; Marco Lastilla; Giuseppe De Lorenzo; Mario Stefano Peragallo; Tommaso Stroffolini; Raffaele D'Amelio
Journal:  Biomedicines       Date:  2022-08-22

5.  Immunogenicity of Viral Vaccines in the Italian Military.

Authors:  Claudia Ferlito; Roberto Biselli; Vincenzo Visco; Maria Sofia Cattaruzza; Maria Rosaria Capobianchi; Concetta Castilletti; Daniele Lapa; Loredana Nicoletti; Antonella Marchi; Fabio Magurano; Anna Rita Ciccaglione; Paola Chionne; Elisabetta Madonna; Isabella Donatelli; Laura Calzoletti; Concetta Fabiani; Michela Ileen Biondo; Raffaela Teloni; Sabrina Mariotti; Gerardo Salerno; Andrea Picchianti-Diamanti; Simonetta Salemi; Sara Caporuscio; Alberto Autore; Patrizia Lulli; Francesco Borelli; Marco Lastilla; Roberto Nisini; Raffaele D'Amelio
Journal:  Biomedicines       Date:  2021-01-17

6.  Hepatitis A in Puglia (South Italy) after 10 years of universal vaccination: need for strict monitoring and catch-up vaccination.

Authors:  Maria Chironna; Rosa Prato; Anna Sallustio; Domenico Martinelli; Silvio Tafuri; Michele Quarto; Cinzia Germinario
Journal:  BMC Infect Dis       Date:  2012-10-25       Impact factor: 3.090

7.  Control of hepatitis A by universal vaccination of adolescents, Puglia, Italy.

Authors:  Pietro Luigi Lopalco; Rosa Prato; Maria Chironna; Cinzia Germinario; Michele Quarto
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.